These healthcare players offer you dividends and a strong earnings picture.
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
Abbott (ABT) concluded the recent trading session at $103.45, signifying a -0.22% move from its prior day's close.